Clinical Trials Browser

Phase 1 × Prostatic Neoplasms × Drug Therapy × Clear all

NCT00002677 2019-11-04

Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors

Phase 1 Completed

Prostatic Neoplasms